These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9720465)

  • 1. In vitro activity of HMR 3647 against anaerobic bacteria.
    Edlund C; Sillerström E; Wahlund E; Nord CE
    J Chemother; 1998 Aug; 10(4):280-4. PubMed ID: 9720465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteria.
    Wexler HM; Molitoris E; Molitoris D; Finegold SM
    J Antimicrob Chemother; 2001 Apr; 47(4):467-9. PubMed ID: 11266423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans.
    Goldstein EJ; Citron DM; Hunt Gerardo S; Hudspeth M; Merriam CV
    Antimicrob Agents Chemother; 1998 May; 42(5):1127-32. PubMed ID: 9593139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004).
    Ednie LM; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Sep; 41(9):2019-22. PubMed ID: 9303406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five beta-lactams, clindamycin, and metronidazole.
    Ednie LM; Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 May; 41(5):1037-41. PubMed ID: 9145865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
    Credito KL; Ednie LM; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2027-31. PubMed ID: 10428930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of telithromycin (HMR 3647, RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and other antimicrobial agents against unusual anaerobes.
    Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2801-5. PubMed ID: 10543769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of anaerobic bacteria to Sch 34343 and other antibiotics.
    Glupczynski Y; Gordts B; van der Linden MP; Labbé M; Yourassowsky E; Butzler JP
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():193-8. PubMed ID: 4030548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of telithromycin (HMR 3647) and seven other antimicrobial agents against anaerobic bacteria.
    Ackermann G; Schaumann R; Pless B; Claros MC; Rodloff AC
    J Antimicrob Chemother; 2000 Jul; 46(1):115-9. PubMed ID: 10882699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro activities of ABT-773 against 362 clinical isolates of anaerobic bacteria.
    Citron DM; Appleman MD
    Antimicrob Agents Chemother; 2001 Jan; 45(1):345-8. PubMed ID: 11120995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of ABT-773 against anaerobic bacteria.
    Sillerström E; Wahlund E; Nord CE
    Eur J Clin Microbiol Infect Dis; 2000 Aug; 19(8):635-7. PubMed ID: 11014629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
    Alados JC; Martínez-Brocal A; Miranda C; Rojo MD; García V; Domínguez MC; de la Rosa M
    Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):219-22. PubMed ID: 1863621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of L-627 against anaerobic bacteria.
    Nord CE; Lindmark A; Persson I
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):757-60. PubMed ID: 1425740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
    Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
    Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in-vitro activity of Sch 34343 and other antimicrobial agents against anaerobic bacteria.
    Nord CE; Olsson-Liljequist B
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():183-8. PubMed ID: 2863246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in-vitro activity of HMR 3647, a new ketolide antimicrobial agent.
    Boswell FJ; Andrews JM; Ashby JP; Fogarty C; Brenwald NP; Wise R
    J Antimicrob Chemother; 1998 Dec; 42(6):703-9. PubMed ID: 10052892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of faropenem against 579 strains of anaerobic bacteria.
    Wexler HM; Molitoris D; St John S; Vu A; Read EK; Finegold SM
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3669-75. PubMed ID: 12384389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of anaerobic bacteria in Auckland: 1991-1996.
    Shore KP; Pottumarthy S; Morris AJ
    N Z Med J; 1999 Nov; 112(1099):424-6. PubMed ID: 10678225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria.
    Edlund C; Sabouri S; Nord CE
    Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):193-5. PubMed ID: 9665302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.